Inoperable chronic thromboembolic pulmonary hypertension: Evolution of prognosis over 10 years of new emerging therapies
Publication date
2024-07
Authors
Staal, Diederik P
Hendriks, Paul M
van Thor, Mitch C J
van de Groep, Liza D
van den Toorn, Leon M
Mulder, Berend-Jan M
Chandoesing, Prewesh P
Kauling, Robert M
Boerman, Sanne
van den Bosch, Annemien E
Editors
Advisors
Supervisors
Document Type
Letter
Metadata
Show full item recordCollections
License
cc_by_nc
Abstract
Therapies for inoperable chronic thromboembolic pulmonary hypertension (CTEPH) include balloon pulmonary angioplasty (BPA) and PH-specific medical therapy. This study compares survival and its predictors before and after the introduction of BPA. BPA was independently associated with survival; however, there was no difference in overall survival between the two cohorts.
Keywords
chronic thromboembolic pulmonary hypertension, prognosis, pulmonary embolism, pulmonary hypertension, survival, Pulmonary and Respiratory Medicine, Journal Article
Citation
Staal, D P, Hendriks, P M, van Thor, M C J, van de Groep, L D, van den Toorn, L M, Mulder, B-J M, Chandoesing, P P, Kauling, R M, Boerman, S, van den Bosch, A E, Mager, J J, Boomars, K A & Post, M C 2024, 'Inoperable chronic thromboembolic pulmonary hypertension : Evolution of prognosis over 10 years of new emerging therapies', Pulmonary Circulation, vol. 14, no. 3, e12419. https://doi.org/10.1002/pul2.12419